Christopher Keenan Email

VP, Investor Relations & Corporate Communications . Pliant Therapeutics

South San Francisco, CA

Location

Current Roles

Employees:
164
Revenue:
$10M
About
Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. By harnessing the therapeutic potential of integrin biology and TGF- modulation, Pliant aims to prevent or even reverse fibrosis to address the needs of many patients. The company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery. Pliant's co-founders include world-renowned researchers from University of California, San Francisco (UCSF), who bring broad experience in fibrosis biology and small molecule chemistry. Together, the Pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.
Pliant Therapeutics Address
260 Littlefield Ave
South San Francisco, CA
United States

Past Companies

Pliant TherapeuticsVice President, Investor Relations & Corporate Communications
CytomX TherapeuticsVice President, Investor Relations & Corporate Communications
Depomed, Inc.Vice President, Investor Relations & Corporate Communications, Depomed, Inc.

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.